J Korean Soc Radiol.  2023 Sep;84(5):999-1008. 10.3348/jksr.2023.0075.

Application of Radiofrequency Ablation to Thyroid Cancer: Past, Present, and Future

• Kim Jh

• KMID: 2546669
• DOI: http://doi.org/10.3348/jksr.2023.0075

Abstract

Thyroid cancer, characterized by high incidence rates, good prognosis, and frequent recurrence, is typically treated surgically. However, since the early 2000s, radiofrequency ablation, which is commonly utilized in liver, lung, and kidney cancers, is being performed for management of primary and recurrent thyroid cancers. Many studies have focused on inoperable cases of low-risk papillary microcarcinoma (≤ 1 cm) and some have investigated its role in larger lesions (up to 4 cm). Overall, these studies have reported positive results. Radiofrequency ablation for recurrent cancer has primarily been performed for locally recurrent cervical cancer, and this therapeutic approach has been attempted for treatment of distant metastases in lungs and bones, with encouraging outcomes. A growing global trend, particularly in South Korea, the United States, and Europe supports radiofrequency ablation for thyroid cancer. However, this therapy is currently not recognized as a treatment option recommended by universally accepted clinical guidelines such as those established by the National Comprehensive Cancer Network. Based on past efforts and future research, radiofrequency ablation is expected to play a key role in thyroid cancer treatment in the near future.

Keyword

Thyroid Neoplasms; Papillary Thyroid Microcarcioma; Neoplasm Recurrence; Radiofrequency Ablation